Peter Thiel Bets Big On "Mushroom Boom."
LSD and "Mushroom stocks" are being listed on the NASDAQ and a recent breakthrough makes top investors VERY excited about the coming "Mushroom Boom."
Click Here To Read The Full Story

NXG Insider Trading (NexgenRx)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$10,580.00
Insider Selling (Last 12 Months): C$0.00

NexgenRx Insider Trading History Chart

NexgenRx Share Price & Price History

▼ -0.015 (-4.41%)
As of 06/21/2021 04:50 PM ET
Days: 30 | 90 | 365
Revealed: A Real Solution for Depression?
Depression is the leading cause of disability worldwide. For nearly 100 million people… there's no known solution. That's right. Nearly one-third of the world's 322 million people suffering from depression have no existing treatment. But that's all about to change.
Here's how you could capitalize off this

NexgenRx Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/12/2020Paul Everett CrossettInsiderBuy23,500C$0.15C$3,525.002,186,638
9/11/2020Paul Everett CrossettInsiderBuy23,500C$0.17C$3,995.002,150,138
8/28/2020Paul Everett CrossettInsiderBuy18,000C$0.17C$3,060.002,126,638
6/5/2020Paul Everett CrossettInsiderBuy55,000C$0.18C$9,625.002,108,638
11/11/2019Paul Everett CrossettInsiderBuy16,000C$0.22C$3,520.001,876,638
11/8/2019Paul Everett CrossettInsiderBuy1,000C$0.22C$220.001,860,638
7/23/2019Paul Everett CrossettInsiderBuy500C$0.24C$120.001,729,138
7/19/2019Paul Everett CrossettInsiderBuy20,000C$0.24C$4,800.001,728,638
12/12/2018Paul Everett CrossettInsiderBuy1,000C$0.25C$250.00
12/6/2018Paul Everett CrossettInsiderBuy5,000C$0.25C$1,250.00
12/3/2018Paul Everett CrossettInsiderBuy24,000C$0.28C$6,720.00
11/29/2018Paul Everett CrossettInsiderBuy18,500C$0.28C$5,180.00
11/27/2018Paul Everett CrossettInsiderBuy17,500C$0.28C$4,900.00
11/20/2018Paul Everett CrossettInsiderBuy24,500C$0.28C$6,860.00
11/13/2018Paul Everett CrossettInsiderBuy20,000C$0.29C$5,800.00
11/9/2018Paul Everett CrossettInsiderBuy6,500C$0.28C$1,820.00
10/31/2018Paul Everett CrossettInsiderBuy1,000C$0.28C$280.00
10/29/2018Paul Everett CrossettInsiderBuy5,000C$0.28C$1,400.00
10/26/2018Paul Everett CrossettInsiderBuy2,000C$0.28C$560.00
10/24/2018Paul Everett CrossettInsiderBuy9,000C$0.28C$2,520.00
10/22/2018Paul Everett CrossettInsiderBuy10,000C$0.30C$3,000.00
10/15/2018Paul Everett CrossettInsiderBuy10,000C$0.24C$2,400.00
10/10/2018Paul Everett CrossettInsiderBuy34,500C$0.25C$8,625.00
10/4/2018Paul Everett CrossettInsiderBuy13,000C$0.24C$3,120.00
9/24/2018Paul Everett CrossettInsiderBuy26,500C$0.25C$6,625.00
9/20/2018Paul Everett CrossettInsiderBuy500C$0.25C$125.00
9/17/2018Paul Everett CrossettInsiderBuy5,000C$0.25C$1,250.00
9/12/2018Paul Everett CrossettInsiderBuy12,000C$0.25C$3,000.00
9/4/2018Paul Everett CrossettInsiderBuy1,000C$0.25C$250.00
8/27/2018Paul Everett CrossettInsiderBuy31,000C$0.26C$8,060.00
7/20/2018Paul Everett CrossettInsiderBuy30,000C$0.23C$6,900.00
See Full Table
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans in Canada. It offers prescription drug claims; dental claims; and claims for extended health benefits, as well as provides a health care spending account that offers an amount of money to an individual to pay for health or dental benefits. The company also provides individual and aggregate stop loss products; medical emergency and travel assistance insurance services; administrative services, including the collection and payment of premiums for life and LTD coverage, as well as a suite of reporting tools; Web claims submission services; direct deposit services; and ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.
Read More on NexgenRx

Today's Range

Now: C$0.33

50 Day Range

MA: C$0.36

52 Week Range

Now: C$0.33


37,500 shs

Average Volume

30,556 shs

Market Capitalization

C$22.86 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of NexgenRx?

NexgenRx's top insider shareholders include:
  1. Paul Everett Crossett (Insider)
Is this Seattle Penny Pot Stock a Potential Blockbuster?
A small, rapidly expanding Seattle cannabis company is gaining attention from investors. Founded by two cannabis veterans, the company has increased sales 8-fold and is looking to double sales again in the next two years. Now selling for less than $1 per share, this is an opportunity to acquire thousands of shares – a potential windfall.
Get Free Report on #1 Cannabis Pick for 2021